Deal Making

Featured on Deal Making

Catalent commits to pDNA, buying Delphi and expanding a Maryland plant
Facilities & Capacity
Catalent commits to pDNA, buying Delphi and expanding a Maryland plantCatalent commits to pDNA, buying Delphi and expanding a Maryland plant

Having its own plasmid DNA capabilities will launch Catalent into areas like mRNA and non-viral gene delivery, the CDMO says.

byDan Stanton, Editorial director
Feb 24, 2021
|
3 Min Read
CDMO to build $490m MAb plant as GSK exits UK site
Bioprocess Insider
CDMO to build $490m MAb plant as GSK exits UK siteCDMO to build $490m MAb plant as GSK exits UK site
byMillie Nelson
Feb 22, 2021
2 Min Read
Ensoma launches to deliver ‘off-the-shelf’ genomic medicine
Therapeutic Class
Ensoma launches to deliver ‘off-the-shelf’ genomic medicineEnsoma launches to deliver ‘off-the-shelf’ genomic medicine
byBen Hargreaves
Feb 22, 2021
2 Min Read
IDT Biologika latest to join AstraZeneca in COVID-19 response
Bioprocess Insider
IDT Biologika latest to join AstraZeneca in COVID-19 responseIDT Biologika latest to join AstraZeneca in COVID-19 response
byMillie Nelson
Feb 18, 2021
2 Min Read
Charles River to reenter CDMO space in $875m Cognate buy
Deal-Making
Charles River to reenter CDMO space in $875m Cognate buyCharles River to reenter CDMO space in $875m Cognate buy
byDan Stanton
Feb 18, 2021
3 Min Read
Ins and outs: High level changes at Merck, Lilly and Editas
Bioprocess Insider
Ins and outs: High level changes at Merck, Lilly and EditasIns and outs: High level changes at Merck, Lilly and Editas
byMillie Nelson
Feb 10, 2021
4 Min Read

More from Deal Making

CGT services round-up: News from Catalent, Thermo Fisher and Aruvant
Bioprocess Insider
CGT services round-up: News from Catalent, Thermo Fisher and Aruvant
CGT services round-up: News from Catalent, Thermo Fisher and Aruvant
Feb 8, 2021
|
2 Min Read
byMillie Nelson, Editor
Gilead Sciences partner with Gritstone for potential HIV cure
Bioprocess Insider
Gilead Sciences partner with Gritstone for potential HIV cure
Gilead Sciences partner with Gritstone for potential HIV cure
Feb 8, 2021
|
2 Min Read
byMillie Nelson, Editor
Wacker acquires plasmid DNA manufacturer Genopis for $39m
Bioprocess Insider
Wacker acquires plasmid DNA manufacturer Genopis for $39m
Wacker acquires plasmid DNA manufacturer Genopis for $39m
Feb 4, 2021
|
2 Min Read
byMillie Nelson, Editor
Merck partners with Artiva to develop off-the-shelf CAR-NK therapies
Bioprocess Insider
Merck partners with Artiva to develop off-the-shelf CAR-NK therapies
Merck partners with Artiva to develop off-the-shelf CAR-NK therapies
Feb 3, 2021
|
2 Min Read
byMillie Nelson, Editor
Just-Evotec Biologics expands COVID-19 contract with DOD
Bioprocess Insider
Just-Evotec Biologics expands COVID-19 contract with DOD
Just-Evotec Biologics expands COVID-19 contract with DOD
Feb 2, 2021
|
2 Min Read
byMillie Nelson, Editor
Filling in its drug product offering: Cytiva buys Vanrx Pharmasystems
Upstream & Downstream Processing
Filling in its drug product offering: Cytiva buys Vanrx Pharmasystems
Filling in its drug product offering: Cytiva buys Vanrx Pharmasystems
Feb 1, 2021
|
1 Min Read
byBPI Staff
Bio-CDMOs remain in the small molecule game despite divestments
Facilities & Capacity
Bio-CDMOs remain in the small molecule game despite divestments
Bio-CDMOs remain in the small molecule game despite divestments
Jan 29, 2021
|
3 Min Read
byDan Stanton, Editorial director
Ajinomoto: Deal for Humanigen’s COVID MAb will save time and money
Bioprocess Insider
Ajinomoto: Deal for Humanigen’s COVID MAb will save time and money
Ajinomoto: Deal for Humanigen’s COVID MAb will save time and money
Jan 28, 2021
|
2 Min Read
byGareth Macdonald
Astrea licenses Avacta’s Affimer reagent technology
Upstream & Downstream Processing
Astrea licenses Avacta’s Affimer reagent technology
Astrea licenses Avacta’s Affimer reagent technology
Jan 25, 2021
|
2 Min Read
byBPI Staff
MA center aims to speed up manufacturing for researchers, says Cytiva
Bioprocess Insider
MA center aims to speed up manufacturing for researchers, says Cytiva
MA center aims to speed up manufacturing for researchers, says Cytiva
Jan 22, 2021
|
2 Min Read
byMillie Nelson, Editor
Regeneron confident it can scale-up to meet US COVID MAb demands
Bioprocess Insider
Regeneron confident it can scale-up to meet US COVID MAb demands
Regeneron confident it can scale-up to meet US COVID MAb demands
Jan 21, 2021
|
2 Min Read
byMillie Nelson, Editor
CDMO round-up: News from Baxter, AMRI, Lonza and Fujifilm
Bioprocess Insider
CDMO round-up: News from Baxter, AMRI, Lonza and Fujifilm
CDMO round-up: News from Baxter, AMRI, Lonza and Fujifilm
Jan 18, 2021
|
3 Min Read
byMillie Nelson, Editor
Thermo Fisher adds EU viral vector plants in €725m Novasep deal
Deal-Making
Thermo Fisher adds EU viral vector plants in €725m Novasep deal
Thermo Fisher adds EU viral vector plants in €725m Novasep deal
Jan 15, 2021
|
2 Min Read
byDan Stanton, Editorial director
Double Dutch: Cristal and Intravacc team on vaccine tech
Deal-Making
Double Dutch: Cristal and Intravacc team on vaccine tech
Double Dutch: Cristal and Intravacc team on vaccine tech
Jan 15, 2021
|
2 Min Read
byDan Stanton, Editorial director
Sanofi shells out $1.1bn for immunology MAb maker Kymab
Deal-Making
Sanofi shells out $1.1bn for immunology MAb maker Kymab
Sanofi shells out $1.1bn for immunology MAb maker Kymab
Jan 11, 2021
|
2 Min Read
byBPI Staff
COVID vaccine success accelerating the mRNA space, MilliporeSigma
Deal-Making
COVID vaccine success accelerating the mRNA space, MilliporeSigma
COVID vaccine success accelerating the mRNA space, MilliporeSigma
Jan 11, 2021
|
2 Min Read
byDan Stanton, Editorial director
Bayer joins Wacker and Fareva in CureVac’s COVID-19 vaccine network
Deal-Making
Bayer joins Wacker and Fareva in CureVac’s COVID-19 vaccine network
Bayer joins Wacker and Fareva in CureVac’s COVID-19 vaccine network
Jan 8, 2021
|
2 Min Read
byGareth Macdonald
Up on the downstream: Sartorius to buy Novasep’s chromatography division
Upstream & Downstream Processing
Up on the downstream: Sartorius to buy Novasep’s chromatography division
Up on the downstream: Sartorius to buy Novasep’s chromatography division
Jan 6, 2021
|
2 Min Read
byDan Stanton, Editorial director
WuXi to make COVID-19 vaccine at shelved Bayer hemophilia drug plant
Facilities & Capacity
WuXi to make COVID-19 vaccine at shelved Bayer hemophilia drug plant
WuXi to make COVID-19 vaccine at shelved Bayer hemophilia drug plant
Jan 4, 2021
|
2 Min Read
byGareth Macdonald
SK Holdings set to jump into cell and gene CDMO space with Yposkesi buy
Deal-Making
SK Holdings set to jump into cell and gene CDMO space with Yposkesi buy
SK Holdings set to jump into cell and gene CDMO space with Yposkesi buy
Dec 18, 2020
|
2 Min Read
byDan Stanton, Editorial director
Inovio contracts Kaneka for plasmid DNA COVID vaccine
Facilities & Capacity
Inovio contracts Kaneka for plasmid DNA COVID vaccine
Inovio contracts Kaneka for plasmid DNA COVID vaccine
Dec 17, 2020
|
1 Min Read
byMillie Nelson, Editor
Eli Lilly $880m Prevail buy a ‘good entry point’ into gene therapy
Deal-Making
Eli Lilly $880m Prevail buy a ‘good entry point’ into gene therapy
Eli Lilly $880m Prevail buy a ‘good entry point’ into gene therapy
Dec 16, 2020
|
2 Min Read
byDan Stanton, Editorial director
AstraZeneca’s $39bn Alexion buy will add meds and manufacturing capacity
Deal-Making
AstraZeneca’s $39bn Alexion buy will add meds and manufacturing capacity
AstraZeneca’s $39bn Alexion buy will add meds and manufacturing capacity
Dec 14, 2020
|
2 Min Read
byGareth Macdonald
Boehringer Ingelheim re-enters ADC space with $1.4bn NBE buy
Deal-Making
Boehringer Ingelheim re-enters ADC space with $1.4bn NBE buy
Boehringer Ingelheim re-enters ADC space with $1.4bn NBE buy
Dec 11, 2020
|
2 Min Read
byDan Stanton, Editorial director
Fareva enhancer: CureVac to use CDMO for COVID vaccine fill/finish
Facilities & Capacity
Fareva enhancer: CureVac to use CDMO for COVID vaccine fill/finish
Fareva enhancer: CureVac to use CDMO for COVID vaccine fill/finish
Dec 9, 2020
|
2 Min Read
byDan Stanton, Editorial director
Sinovac raises $500m to fund Coronavac trials and production
Deal-Making
Sinovac raises $500m to fund Coronavac trials and production
Sinovac raises $500m to fund Coronavac trials and production
Dec 9, 2020
|
2 Min Read
byGareth Macdonald
BioLife invests in viral vector and freeze media tech firms
Deal-Making
BioLife invests in viral vector and freeze media tech firms
BioLife invests in viral vector and freeze media tech firms
Dec 4, 2020
|
2 Min Read
byDan Stanton, Editorial director
Atbtherapeutics secures plant-based production of targeted antibodies
Deal-Making
Atbtherapeutics secures plant-based production of targeted antibodies
Atbtherapeutics secures plant-based production of targeted antibodies
Dec 4, 2020
|
2 Min Read
byDan Stanton, Editorial director
Lonza building dedicated conjugation suites for ADC client
Deal-Making
Lonza building dedicated conjugation suites for ADC client
Lonza building dedicated conjugation suites for ADC client
Dec 2, 2020
|
3 Min Read
byDan Stanton, Editorial director
Mustang expands ‘bubble boy’ gene therapy footprint with European CDMO
Facilities & Capacity
Mustang expands ‘bubble boy’ gene therapy footprint with European CDMO
Mustang expands ‘bubble boy’ gene therapy footprint with European CDMO
Nov 26, 2020
|
2 Min Read
byDan Stanton, Editorial director

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe